North East and North Cumbria Formulary


	North East and North Cumbria ICS Formulary

Search

Results

Looking for Fulvestrant found 9 matches

Open monograph to display formulary status		BNF Category
	Fulvestrant (Faslodex^®)	Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
	Abemaciclib (Verzenios^®)	Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
	Alpelisib (Piqray^®)	Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
	Palbociclib (Ibrance^®)	Malignant disease and immunosuppression - Breast cancer - 08.03.04.01

Links

Link to Drug Section

Link to document

NICE TA239: Fulvestrant for the treatment of locally advanced or metastatic breast cancer (08.03.04.01)

NICE TA687: Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)

NICE TA725: Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)

NICE TA816: Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer (08.03.04.01)

NICE TA836: Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)